BIOHEART-B(02185) has appointed GIORGIO GOBBI as Vice President of Global Therapeutic Development at Antong.
Boxin An-B (02185) announced that Mr. Giorgio Gobbi, a former senior executive at Medtronic and ReCor Medical, has joined the company's non-wholly-owned subsidiary, Shanghai Antong Medical Technology Co., Ltd. (Antong), as the Vice President of Global Therapy Development. He will be fully responsible for the global therapy development work of the Iberis renal denervation (RDN) system.
BIOHEART-B (02185) announced that Mr. Giorgio Gobbi, a former senior executive at Medtronic and ReCor Medical, has joined the company's non-wholly-owned subsidiary, Shanghai Antong Medical Technology Co., Ltd. (Antong), as Vice President of Global Therapy Development. He will be fully responsible for the global therapy development of the Iberis renal denervation (RDN) system.
Related Articles
Dencare (001328.SZ) indirect controlling shareholders concerted action party intends to reduce its holdings by no more than 1.74%.
POLY XVERSE IT (00209): Zhao Kai resigns as Chairman and Executive Director
HOMELAND ITL (03798) repurchased 10,000 shares for HKD 12,000 on September 7.
Dencare (001328.SZ) indirect controlling shareholders concerted action party intends to reduce its holdings by no more than 1.74%.
POLY XVERSE IT (00209): Zhao Kai resigns as Chairman and Executive Director
HOMELAND ITL (03798) repurchased 10,000 shares for HKD 12,000 on September 7.
RECOMMEND
